Blossom Inc. purchased a non-renewable licensing agreement for access to proprietary technology that allows it to produce bio-char from organic waste. When the 10-year licensing agreement was purchased 6 years ago there were no other companies operating in the space. However, numerous competitors have emerged in the industry as direct competitors to Blossom Inc. As a result of recent market entrants, the market demand for its bio-char products has been steadily declining. The company has the following information available related to the licensing agreement: Licensing agreement at Cost Estimated Useful Life Residual Value $124,500 10 years $0 Blossom Inc. is currently testing this asset for impairment. While the licensing agreement could currently be sold for $39,800, Blossom Inc. plans to keep producing the bio-char two more years. It expects net cash flows from production to be $20,900 yearly and hat it can sell the licensing agreement for $7,400 at the end of year two. The current interest rate is 5%.
Blossom Inc. purchased a non-renewable licensing agreement for access to proprietary technology that allows it to produce bio-char from organic waste. When the 10-year licensing agreement was purchased 6 years ago there were no other companies operating in the space. However, numerous competitors have emerged in the industry as direct competitors to Blossom Inc. As a result of recent market entrants, the market demand for its bio-char products has been steadily declining. The company has the following information available related to the licensing agreement: Licensing agreement at Cost Estimated Useful Life Residual Value $124,500 10 years $0 Blossom Inc. is currently testing this asset for impairment. While the licensing agreement could currently be sold for $39,800, Blossom Inc. plans to keep producing the bio-char two more years. It expects net cash flows from production to be $20,900 yearly and hat it can sell the licensing agreement for $7,400 at the end of year two. The current interest rate is 5%.
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
Related questions
Question
Godo
![Blossom Inc. purchased a non-renewable licensing agreement for access to proprietary technology that allows it to produce bio-char
from organic waste. When the 10-year licensing agreement was purchased 6 years ago there were no other companies operating in
the space. However, numerous competitors have emerged in the industry as direct competitors to Blossom Inc. As a result of recent
market entrants, the market demand for its bio-char products has been steadily declining. The company has the following information
available related to the licensing agreement:
Licensing agreement at Cost
Estimated Useful Life
Residual Value
$124,500
10 years
$0
فى
Blossom Inc. is currently testing this asset for impairment. While the licensing agreement could currently be sold for $39,800,
Blossom Inc. plans to keep producing the bio-char two more years. It expects net cash flows from production to be $20,900 yearly and
that it can sell the licensing agreement for $7,400 at the end of year two. The current interest rate is 5%.](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F323c9976-6b7b-4414-aa82-41105edc66ec%2F415bbbcd-ca58-4658-b08e-e3ac71cd8460%2Fom2pmye_processed.jpeg&w=3840&q=75)
Transcribed Image Text:Blossom Inc. purchased a non-renewable licensing agreement for access to proprietary technology that allows it to produce bio-char
from organic waste. When the 10-year licensing agreement was purchased 6 years ago there were no other companies operating in
the space. However, numerous competitors have emerged in the industry as direct competitors to Blossom Inc. As a result of recent
market entrants, the market demand for its bio-char products has been steadily declining. The company has the following information
available related to the licensing agreement:
Licensing agreement at Cost
Estimated Useful Life
Residual Value
$124,500
10 years
$0
فى
Blossom Inc. is currently testing this asset for impairment. While the licensing agreement could currently be sold for $39,800,
Blossom Inc. plans to keep producing the bio-char two more years. It expects net cash flows from production to be $20,900 yearly and
that it can sell the licensing agreement for $7,400 at the end of year two. The current interest rate is 5%.
![Assume that Blossom Inc., follows IFRS and uses the rational entity model. Calculate the carrying amount and recoverable
amount. (Round answers to 0 decimal places, e.g. 5,275.)
Carrying amount of the licensing agreement
Recoverable amount
$
Yes
No
GA
Is there an impairment loss? If yes, how much is the amount? (Round answer to O decimal places, e.g. 5,275.)](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F323c9976-6b7b-4414-aa82-41105edc66ec%2F415bbbcd-ca58-4658-b08e-e3ac71cd8460%2Fiw2ss4s_processed.jpeg&w=3840&q=75)
Transcribed Image Text:Assume that Blossom Inc., follows IFRS and uses the rational entity model. Calculate the carrying amount and recoverable
amount. (Round answers to 0 decimal places, e.g. 5,275.)
Carrying amount of the licensing agreement
Recoverable amount
$
Yes
No
GA
Is there an impairment loss? If yes, how much is the amount? (Round answer to O decimal places, e.g. 5,275.)
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 5 steps
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.Recommended textbooks for you
![FINANCIAL ACCOUNTING](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781259964947/9781259964947_smallCoverImage.jpg)
![Accounting](https://www.bartleby.com/isbn_cover_images/9781337272094/9781337272094_smallCoverImage.gif)
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
![Accounting Information Systems](https://www.bartleby.com/isbn_cover_images/9781337619202/9781337619202_smallCoverImage.gif)
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
![FINANCIAL ACCOUNTING](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9781259964947/9781259964947_smallCoverImage.jpg)
![Accounting](https://www.bartleby.com/isbn_cover_images/9781337272094/9781337272094_smallCoverImage.gif)
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
![Accounting Information Systems](https://www.bartleby.com/isbn_cover_images/9781337619202/9781337619202_smallCoverImage.gif)
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
![Horngren's Cost Accounting: A Managerial Emphasis…](https://www.bartleby.com/isbn_cover_images/9780134475585/9780134475585_smallCoverImage.gif)
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
![Intermediate Accounting](https://www.bartleby.com/isbn_cover_images/9781259722660/9781259722660_smallCoverImage.gif)
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
![Financial and Managerial Accounting](https://www.bartleby.com/isbn_cover_images/9781259726705/9781259726705_smallCoverImage.gif)
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education